Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
NVS Novartis AG
- Stocks
- Healthcare
- NYSE: NVS
Price (delayed)
$108.95
Market cap
$213.47B
P/E Ratio
16.92
Dividend/share
$3.87
EPS
$6.44
Enterprise value
$237.67B
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world
Highlights
The gross profit rose by 15% year-on-year and by 3.5% since the previous quarter
Novartis AG's revenue has increased by 11% YoY and by 2.9% QoQ
The company's net income fell by 16% YoY but it rose by 8% QoQ
The company's EPS fell by 13% YoY but it rose by 9% QoQ
The quick ratio is down by 32% since the previous quarter and by 17% year-on-year
The company's debt rose by 15% YoY
Key stats
What are the main financial stats of NVS
Market
Valuations
Earnings
Shares outstanding
1.96B
Market cap
$213.47B
Enterprise value
$237.67B
Price to earnings (P/E)
16.92
Price to book (P/B)
5.61
Price to sales (P/S)
4.03
EV/EBIT
14.88
EV/EBITDA
9
EV/Sales
4.47
Revenue
$53.22B
Gross profit
$40.26B
Operating income
$15.83B
Net income
$12.86B
EBIT
$15.97B
EBITDA
$26.42B
Free cash flow
$17.7B
Per share
Balance sheet
Liquidity
EPS
$6.44
EPS diluted
$6.38
Free cash flow per share
$8.99
Book value per share
$19.43
Revenue per share
$27.04
TBVPS
$24.14
Total assets
$99.94B
Total liabilities
$61.49B
Debt
$31.27B
Equity
$38.37B
Working capital
-$6.51B
Debt to equity
0.81
Current ratio
0.79
Quick ratio
0.5
Net debt/EBITDA
0.92
Margins
Efficiency
Dividend
EBITDA margin
49.6%
Gross margin
75.7%
Net margin
24.2%
Operating margin
29.8%
Return on assets
12.8%
Return on equity
30.7%
Return on invested capital
39.7%
Return on capital employed
23.4%
Return on sales
30%
Dividend yield
3.55%
DPS
$3.87
Payout ratio
60.1%
NVS stock price
How has the Novartis AG stock price performed over time
Intraday
0.23%
1 week
-3.65%
1 month
1.33%
1 year
6.71%
YTD
11.96%
QTD
-2.27%
Financial performance
How have Novartis AG's revenue and profit performed over time
Revenue
$53.22B
Gross profit
$40.26B
Operating income
$15.83B
Net income
$12.86B
Gross margin
75.7%
Net margin
24.2%
NVS's operating income has soared by 50% year-on-year and by 9% since the previous quarter
NVS's operating margin is up by 35% year-on-year and by 6% since the previous quarter
The company's net margin fell by 24% YoY but it rose by 4.8% QoQ
The company's net income fell by 16% YoY but it rose by 8% QoQ
Price vs fundamentals
How does NVS's price correlate with its fundamentals
Growth
What is Novartis AG's growth rate over time
Valuation
What is Novartis AG stock price valuation
P/E
16.92
P/B
5.61
P/S
4.03
EV/EBIT
14.88
EV/EBITDA
9
EV/Sales
4.47
The company's EPS fell by 13% YoY but it rose by 9% QoQ
The stock's P/E is 11% more than its last 4 quarters average of 15.2 but 11% less than its 5-year quarterly average of 19.0
NVS's P/B is 40% above its 5-year quarterly average of 4.0 and 8% above its last 4 quarters average of 5.2
The company's equity fell by 13% QoQ and by 3.3% YoY
Novartis AG's revenue has increased by 11% YoY and by 2.9% QoQ
The P/S is 6% less than the 5-year quarterly average of 4.3 and 4% less than the last 4 quarters average of 4.2
Efficiency
How efficient is Novartis AG business performance
The ROIC has declined by 19% year-on-year but it is up by 4.7% since the previous quarter
The company's return on sales fell by 15% YoY but it rose by 6% QoQ
Novartis AG's ROA has decreased by 12% YoY but it has increased by 7% from the previous quarter
NVS's ROE is down by 11% YoY but it is up by 8% QoQ
Dividends
What is NVS's dividend history
DPS
$3.87
Dividend yield
3.55%
Payout ratio
60.1%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Novartis AG financials performed over time
NVS's total assets is 63% greater than its total liabilities
The quick ratio is down by 32% since the previous quarter and by 17% year-on-year
Novartis AG's current ratio has decreased by 24% QoQ and by 12% YoY
The company's debt is 19% lower than its equity
The debt to equity has grown by 17% YoY and by 14% from the previous quarter
The company's debt rose by 15% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.